AMGEN INC — Director's Dealing 2021

Sep 14, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BeiGene, Ltd. (BGNE)
CIK: 0001651308
Period of Report: 2021-09-10

Reporting Person: AMGEN INC (10% Owner)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-09-10	American Depositary Shares	P	165529	$302.0615	Acquired	18943802	Direct

Footnotes

F1: This transaction was made pursuant to that Share Purchase Agreement, dated as of September 24, 2020, as amended, by and between the Reporting Person and the Issuer.

F2: The price reported is the volume weighted average price on the NASDAQ Stock Market LLC of one American Depositary Share ("ADS") of the Issuer for the ninety calendar days preceding August 31, 2021.

F3: As each ADS represents 13 Ordinary Shares of the Issuer, the reported securities represent 246,269,426 Ordinary Shares.